Family history of breast cancer and all-cause mortality after breast cancer diagnosis in the Breast Cancer Family Registry

Breast Cancer Research and Treatment

Volumn 117, Issue 1, 2009, Pages 167-176

  Chang, Ellen T ^a   Milne, Roger L ^c,d   Phillips, Kelly Anne ^d,e   Figueiredo, Jane C ^f,g   Sangaramoorthy, Meera ^a   Keegan, Theresa H M ^a,b   Andrulis, Irene L ^f,h   Hopper, John L ^d   Goodwin, Pamela J ^f,i   O'Malley, Frances P ^f   Weerasooriya, Nayana ^h   Apicella, Carmel ^d   Southey, Melissa C ^d   Friedlander, Michael L ^j   Giles, Graham G ^k   Whittemore, Alice S ^b   West, Dee W ^a,b   John, Esther M ^a,b  

^a NORTHERN CALIFORNIA CANCER CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Centro Nacional de Investigaciones Oncológicas   (Spain)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e PETER MACCALLUM CANCER CENTRE   (Australia)

^f MOUNT SINAI HOSPITAL   (Canada)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^h CANCER CARE ONTARIO   (Canada)

ⁱ UNIVERSITY OF TORONTO   (Canada)

^j PRINCE OF WALES HOSPITAL   (Australia)

^k CANCER EPIDEMIOLOGY CENTRE   (Australia)

more..

Author keywords

Breast cancer; Family history; Mortality; Survival

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER INVASION; CANCER MORTALITY; CANCER RISK; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENE MUTATION; GEOGRAPHIC DISTRIBUTION; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; QUESTIONNAIRE; RISK FACTOR; TUMOR VOLUME;

ADULT; AUSTRALIA; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; MUTATION; ONTARIO; PEDIGREE; PROPORTIONAL HAZARDS MODELS; REGISTRIES; SEER PROGRAM; UNITED STATES;

EID: 69049111858     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-0255-3     Document Type: Article

References (43)

1. PD Pharoah NE Day S Duffy et al. 1997 Family history and the risk of breast cancer: a systematic review and meta-analysis Int J Cancer 71 5 800 809 10.1002/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.0.CO;2-B
2. Collaborative group on hormonal factors in breast cancer 2001 Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease Lancet 358 9291 1389 1399 10.1016/S0140-6736(01)06524- 2
3. MP Lux PA Fasching MW Beckmann 2006 Hereditary breast and ovarian cancer: review and future perspectives J Mol Med 84 1 16 28 10.1007/s00109-005-0696-7
4. MR Stratton N Rahman 2008 The emerging landscape of breast cancer susceptibility Nat Genet 40 1 17 22 10.1038/ng.2007.53
5. PO Chappuis J Rosenblatt WD Foulkes 1999 The influence of familial and hereditary factors on the prognosis of breast cancer Ann Oncol 10 10 1163 1170 10.1023/A:1008301314812
6. H Eerola P Vahteristo L Sarantaus et al. 2001 Survival of breast cancer patients in BRCA1, BRCA2, and non-BRCA1/2 breast cancer families: a relative survival analysis from Finland Int J Cancer 93 3 368 372 10.1002/ijc.1341
7. A Russo A Herd-Smith D Gestri et al. 2002 Does family history influence survival in breast cancer cases? Int J Cancer 99 3 427 430 10.1002/ijc.10342
8. HM Verkooijen PO Chappuis E Rapiti et al. 2006 Impact of familial risk factors on management and survival of early-onset breast cancer: a population-based study Br J Cancer 94 2 231 238 10.1038/sj.bjc.6602914
9. LC Verhoog CT Brekelmans C Seynaeve et al. 1999 Survival in hereditary breast cancer associated with germline mutations of BRCA2 J Clin Oncol 17 11 3396 3402
10. JJ Jobsen JH Meerwaldt J van der Palen 2000 Family history in breast cancer is not a prognostic factor? Breast 9 2 83 87 10.1054/brst.2000.0130
11. G Vlastos NQ Mirza F Meric et al. 2002 Breast-conservation therapy in early-stage breast cancer patients with a positive family history Ann Surg Oncol 9 9 912 919 10.1007/BF02557530
12. A Veronesi C de Giacomi MD Magri et al. 2005 Familial breast cancer: characteristics and outcome of BRCA 1-2 positive and negative cases BMC Cancer 5 70 10.1186/1471-2407-5-70
13. CT Brekelmans MM Tilanus-Linthorst C Seynaeve et al. 2007 Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases Eur J Cancer 43 5 867 876 10.1016/j.ejca.2006.12.009
14. G Rennert S Bisland-Naggan O Barnett-Griness et al. 2007 Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations N Engl J Med 357 2 115 123 10.1056/NEJMoa070608
15. JC Figueiredo M Ennis JA Knight et al. 2007 Influence of young age at diagnosis and family history of breast or ovarian cancer on breast cancer outcomes in a population-based cohort study Breast Cancer Res Treat 105 1 69 80 10.1007/s10549-006-9433-3
16. CT Brekelmans AC Voogd G Botke et al. 1999 Family history of breast cancer and local recurrence after breast-conserving therapy. The Dutch study group on local recurrence after breast conservation (BORST) Eur J Cancer 35 4 620 626 10.1016/S0959-8049(99)00008-8
17. EE Harris DJ Schultz CA Peters et al. 2000 Relationship of family history and outcome after breast conservation therapy in women with ductal carcinoma in situ of the breast Int J Radiat Oncol Biol Phys 48 4 933 941 10.1016/S0360-3016(00)00726-4
18. M Hery T Delozier A Ramaioli et al. 2002 Natural history of node-negative breast cancer: are conventional prognostic factors predictors of time to relapse? Breast 11 5 442 448 10.1054/brst.2002.0462
19. N Rodrigues D Carter D Dillon et al. 2002 Correlation of clinical and pathologic features with outcome in patients with ductal carcinoma in situ of the breast treated with breast-conserving surgery and radiotherapy Int J Radiat Oncol Biol Phys 54 5 1331 1335 10.1016/S0360-3016(02)03747-1
20. PI Tartter C Gajdos S Rosenbaum Smith et al. 2002 The prognostic significance of Gail model risk factors for women with breast cancer Am J Surg 184 1 11 15 10.1016/S0002-9610(02)00885-1
21. S Margolin H Johansson LE Rutqvist et al. 2006 Family history, and impact on clinical presentation and prognosis, in a population-based breast cancer cohort from the Stockholm County Fam Cancer 5 4 309 321 10.1007/s10689-006-7851- 3
22. T Kinoshita T Fukutomi E Iwamoto et al. 2004 Prognosis of breast cancer patients with familial history classified according to their menopausal status Breast J 10 3 218 222 10.1111/j.1075-122X.2004.21288.x
23. N Loman O Johannsson P Bendahl et al. 2000 Prognosis and clinical presentation of BRCA2-associated breast cancer Eur J Cancer 36 11 1365 1373 10.1016/S0959-8049(00)00098-8
24. KA Szelei-Stevens RR Kuske VA Yantsos et al. 2000 The influence of young age and positive family history of breast cancer on the prognosis of ductal carcinoma in situ treated by excision with or without radiation therapy or by mastectomy Int J Radiat Oncol Biol Phys 48 4 943 949 10.1016/S0360-3016(00) 00715-X
25. J Peto N Collins R Barfoot et al. 1999 Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer J Natl Cancer Inst 91 11 943 949 10.1093/jnci/91.11.943
26. Anglian Breast Cancer Study Group 2008 Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases Br J Cancer 83 10 1301 1308 10.1054/bjoc.2000.1407
27. AC Antoniou PD Pharoah G McMullan et al. 2001 Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study Genet Epidemiol 21 1 1 18 10.1002/gepi.1014
28. KA Phillips IL Andrulis PJ Goodwin 1999 Breast carcinomas arising in carriers of mutations in BRCA1 or BRCA2: are they prognostically different? J Clin Oncol 17 11 3653 3663
29. EM John JL Hopper JC Beck et al. 2004 The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer Breast Cancer Res 6 4 R375 R389 10.1186/bcr801
30. JA Knight HJ Sutherland G Glendon et al. 2002 Characteristics associated with participation at various stages at the Ontario site of the cooperative family registry for breast cancer studies Ann Epidemiol 12 1 27 33 10.1016/S1047-2797(01)00253-8
31. Neuhausen SL, Ozcelik H, Southey MC et al (2008) BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research. Breast Cancer Res Treat (in press). doi: 10.1007/s10549-008-0153-8
32. IL Andrulis H Anton-Culver J Beck et al. 2002 Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutations Hum Mutat 20 1 65 73 10.1002/humu.10097
33. A Molino M Giovannini R Pedersini et al. 2004 Correlations between family history and cancer characteristics in 2256 breast cancer patients Br J Cancer 91 1 96 98 10.1038/sj.bjc.6601905
34. JM Murabito JC Evans MG Larson et al. 2001 Family breast cancer history and mammography: Framingham offspring study Am J Epidemiol 154 10 916 923 10.1093/aje/154.10.916
35. L Madlensky RA Vierkant CM Vachon et al. 2005 Preventive health behaviors and familial breast cancer Cancer Epidemiol Biomarkers Prev 14 10 2340 2345 10.1158/1055-9965.EPI-05-0254
36. M Koch GB Hill 1987 Problems in establishing accurate family history in patients with ovarian cancer of epithelial origin Cancer Detect Prev 10 3-4 279 283
37. ME Parent P Ghadirian A Lacroix et al. 1995 Accuracy of reports of familial breast cancer in a case-control series Epidemiology 6 2 184 186 10.1097/00001648-199503000-00018
38. RA Kerber ML Slattery 1997 Comparison of self-reported and database-linked family history of cancer data in a case-control study Am J Epidemiol 146 3 244 248
39. A Ziogas H Anton-Culver 2003 Validation of family history data in cancer family registries Am J Prev Med 24 2 190 198 10.1016/S0749-3797(02)00593-7
40. ET Chang KE Smedby H Hjalgrim et al. 2006 Reliability of self-reported family history of cancer in a large case-control study of lymphoma J Natl Cancer Inst 98 1 61 68
41. SR Lakhani BA Gusterson J Jacquemier et al. 2000 The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2 Clin Cancer Res 6 3 782 789
42. J Palacios E Honrado A Osorio et al. 2003 Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers Clin Cancer Res 9 10 Pt 1 3606 3614
43. AL Bane JC Beck I Bleiweiss et al. 2007 BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays Am J Surg Pathol 31 1 121 128 10.1097/01.pas.0000213351.49767.0f